IL22 and inflammatory bowel disease: Interestingly, the treatment with a later onset attained superior protective results in overall clinical IBD scores and in the inhibition of pro-inflammatory cytokines, while the expression levels of anti-inflammatory IL-10 and tissue-healing IL-22 were increased.